Surge in Life Sciences Investment in Region Continues: 2021 Total Exceeded $12 Billion

The life sciences sector in Greater Philadelphia benefited from robust investment in 2021. The 11-county area of Southeastern Pennsylvania, northern Delaware and southern New Jersey combined saw more than $12 billion invested, according to biopharma database company DealForma. The $12 billion tally included more than $3 billion for cell and gene therapy. Investment deals ranged from Series A rounds through IPOs. Among the technologies funded were biologics, cell and gene therapy, small molecules, as well as medical device and digital health, including artificial intelligence.

Reflected in the DealForma data were eight IPOs with a combined value of more than $750 million. […]

People are Talking about Greater Philadelphia

Isn’t it wonderful when people say something nice about you? That’s a feeling Greater Philadelphia has been experiencing a lot lately, as global publications help amplify what those of us who live here already know – this is a place with a great quality of life.

TIME magazine recognized it when it named Philadelphia one of the “World’s Greatest Places 2021. (July 2021). Outside magazine stated it when it placed Philadelphia on its list of 2021’s Best Towns (October 2021). Condé Nast Traveler spotlighted it when it designated Philadelphia a must-visit destination, one of only eight on its editors’ “The Best […]

CEO of Comcast-IBC joint venture Quil discusses beta testing its next product and ‘hiring like crazy’

The digital health joint venture formed by Comcast Corp. and Independence Blue Cross is set to launch its second product early next year.

Article from Philadelphia Business Journal 

Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo Clinic

Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.

Article from PR Newswire

Philadelphia’s startup ecosystem climbs 15 spots into the top 30 worldwide, report says

Philadelphia’s startup scene is ranked amongst the best-performing in the world according to Startup Genome.

Article from Philadelphia Business Journal 

Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

The U.S. Food and Drug Administration has approved Opzelura™ cream for short-term and non-continuous chronic treatment of atopic dermatitis.

Article from Business Wire

Go to Top